Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

ArchivedFDA

Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed

$1,440,000
Total funding
Feb 1, 2024
Posted
View opportunity →
ArchivedFDA

Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U19) Clinical Trials Not Allowed

$15,000,000
Total funding
Feb 1, 2024
Posted
View opportunity →
ArchivedFDA

Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional

$500,000
Total funding
Jan 31, 2024
Posted
View opportunity →
ArchivedFDA

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

$2,000,000
Total funding
Jan 16, 2024
Posted
View opportunity →
ArchivedFDA

Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed

$300,000
Total funding
Jan 15, 2024
Posted
View opportunity →
ArchivedFDA

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

$300,000
Total funding
Jan 15, 2024
Posted
View opportunity →
ArchivedFDA

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

$300,000
Total funding
Jan 15, 2024
Posted
View opportunity →
ArchivedFDA

Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

$250,000
Total funding
Jan 15, 2024
Posted
View opportunity →
ArchivedFDA

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

$250,000
Total funding
Jan 15, 2024
Posted
View opportunity →
ArchivedFDA

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

$250,000
Total funding
Jan 15, 2024
Posted
View opportunity →
ArchivedFDA

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

$300,000
Total funding
Jan 15, 2024
Posted
View opportunity →
ArchivedFDA

Critical Path Public Private Partnerships Clinical Trials Optional

$20,000,000
Total funding
Jan 4, 2024
Posted
View opportunity →